Found: 1
Select item for more details and to access through your institution.
Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.
- Published in:
- EFSA Journal, 2023, v. 21, n. 2, p. 1, doi. 10.2903/j.efsa.2023.7744
- By:
- Publication type:
- Article